Coverage does exist, but approval is conditional
A new working paper from the National Bureau of Economic Research suggests that weight loss associated with these medications may be linked to improved employment and relationship outcomes for some women a finding that underscores just how deeply appearance and confidence are intertwined in everyday life
GLP-1 medications are designed for subcutaneous fat, not muscle
doi: 10.1111/dom.14725 Mosenzon O, Garvey WT, Hesse D, et al
For me the effect was psychological: not feeling guilty to eat, or annoyed not to
Digbi Healths Precision GLP-1 Program includes: Clinically supervised access to FDA-approved GLP-1 medications, including Wegovy, Ozempic, and Zepbound, with access to an introductory cash price of $199 per month for Ozempic and Wegovy injection pens for Digbi self-pay users, along with clear, transparent pricing and no hidden fees